No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (2)
AQR
$32.5M
added
Gotham Asset
$12.3M
added
Sells/Trims (1)
Millennium
$29.1M
trimmed
Top-trader positions in BAX could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.36 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 23, 2026
EPS expected
$0.50 to $0.54
Revenue expected
11 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $0.56 / $0.36Alpha Vantage | +55.56% beat | $2.96B No estimate | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $0.36 / $0.31Alpha Vantage | +16.13% beat | $2.70B No estimate | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | $0.44 / $0.54Alpha Vantage | -18.52% miss | $2.97B No estimate | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $0.69 / $0.60Alpha Vantage | +15.00% beat | $2.83B No estimate | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $0.59 / $0.61Alpha Vantage | -3.28% miss | $2.81B No estimate | Unavailable |
| Mar 31, 2025 | May 1, 2025 | $0.55 / $0.48Alpha Vantage | +14.58% beat | $2.63B No estimate | Unavailable |
| Dec 31, 2024 | Feb 20, 2025 | $0.58 / $0.52Alpha Vantage | +11.54% beat | $2.75B No estimate | Unavailable |
| Sep 30, 2024 | Nov 8, 2024 | $0.49 / $0.78Alpha Vantage | -37.18% miss | $2.70B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.83B | $2.97B | $2.70B | $2.96B |
| Cost of what it sold | $1.89B | $2.40B | $1.81B | $1.93B |
| Gross profit | $950.0M | $577.0M | $891.0M | $1.03B |
| What it spent | ||||
| Research and development | $118.0M | $126.0M | $139.0M | $129.0M |
| Sales and admin | $708.0M | $761.0M | $728.0M | $735.0M |
| Other operating costs | -$48.0M | $419.0M | -$42.0M | -$49.0M |
| Total operating expenses | $778.0M | $1.31B | $825.0M | $815.0M |
| What was left | ||||
| Operating profit | $172.0M | -$729.0M | $66.0M | $217.0M |
| Interest on debt | $68.0M | $69.0M | $78.0M | $77.0M |
| Profit before tax | $121.0M | -$756.0M | -$6.0M | $158.0M |
| Tax | $172.0M | $279.0M | $11.0M | $23.0M |
| Net profit | -$46.0M | -$1.13B | -$15.0M | $126.0M |
| EBITDA | $426.0M | -$447.0M | $297.0M | $474.0M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace